Scientists say that an experimental monoclonal antibody drug called mAb43 appears to prevent and reverse the onset of clinical type 1 diabetes in mice, and in some cases, to lengthen the animals‘ lifespan.
Quelle: ScienceDaily | Immune System
Titelbild/Grafik: ScienceDaily News
Kommentare und Fragen
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Weiteres von ScienceDaily | Allergy
- New research in fatty liver disease aims to help with early intervention
- In clinical trial, fecal matter transplant helped half of patients with gastrointestinal cancers overcome resistance to immunotherapy treatment
- Blood test may guide use of multiple myeloma immunotherapy
- Brain-heart axis: Strokes change epigenetics of immune system
- Knockout of CD5 on CAR T cells boosts anti-tumor efficacy
- Scientists pinpoint new drug target for RSV
- PEPITEM -- a novel protective agent for 'inflammageing'
- Autoantibodies behind lifelong risk of viral infections
- Influenza viruses can use two ways to infect cells
- Immune system in the spotlight